| -0.55 / -1.16%|
The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 91.00, with a high estimate of 98.00 and a low estimate of 49.00. The median estimate represents a +95.93% increase from the last price of 46.45.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.